<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02975492</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL15_0500</org_study_id>
    <secondary_id>UF 9676</secondary_id>
    <nct_id>NCT02975492</nct_id>
  </id_info>
  <brief_title>Assessing the Impact of a Mode of Vitamin D Supplementation (Sequential Dose vs Daily Dose) on the Incidence of Hypercalciuria in Children Aged From 2 to 6 Years</brief_title>
  <acronym>DonneDVit</acronym>
  <official_title>Evaluation de l'Impact d'un Mode de supplémentation en Vitamine D (Dose séquentielle vs Dose Quotidienne) Sur l'Incidence de l'Hypercalciurie Chez Des Enfants Des départements du Gard et de l'Hérault agés de 2 à 6 Ans. Etude contrôlée randomisée en 2 Groupes parallèles</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recommendations for vitamin D supplementation for children between 2 and 6 years offer strong
      sequential doses of vitamin D: 2 times 100 000 units in spaced winter period of 3 months.
      Data from the literature show a further increase in the incidence of oxalo-calcium stones in
      children and adolescents associated with hypercalciuria with training Randall plates,
      essential step lithogenesis calcium oxalate. Knowing the links between vitamin D and urinary
      calcium excretion, these data lead to the question of increased sensitivity in some children
      with vitamin D, sensitivity could explain these situations with hypercalciuria increase the
      gallstone risk. This increased sensitivity to vitamin D may unmask particularly if inputs of
      high doses of vitamin responsible then a transient hypercalciuria with development of
      microcrystals.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 14, 2017</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">May 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes from calcium level in urines at day 7, day 14 and day 28</measure>
    <time_frame>day 7, day 14 and day 28</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Transient Hypercalciuria</condition>
  <arm_group>
    <arm_group_label>Cholecalciferol sequential dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cholecalciferol : 100 000 Unit International (UI), sequential dose (2 mL)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cholecalciferol daily dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cholecalciferol : 1000 UI, daily dose during 28 days (0.1 ml by day)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol sequential dose</intervention_name>
    <description>sequential dose administration of the treatment</description>
    <arm_group_label>Cholecalciferol sequential dose</arm_group_label>
    <other_name>Vitamin D</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol daily dose</intervention_name>
    <description>daily dose administration of the treatment</description>
    <arm_group_label>Cholecalciferol daily dose</arm_group_label>
    <other_name>Vitamin D</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 2 to 6 years included included

          -  Obtaining informed consent of the parents signed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Denis MORIN, MD</last_name>
    <phone>0467336607</phone>
    <email>d-morin@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pediatric department</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis MORIN, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pediatric department</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tu-Anh TRAN, MD</last_name>
      <phone>04 66 68 32 84</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>November 7, 2016</study_first_submitted>
  <study_first_submitted_qc>November 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2016</study_first_posted>
  <last_update_submitted>January 7, 2020</last_update_submitted>
  <last_update_submitted_qc>January 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercalciuria</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

